November 15, 2011 -- MRI's ability to positively affect so many different clinical areas will be on display at the RSNA 2011 meeting in Chicago. From pediatric and breast imaging to high-field techniques for assessing mild traumatic brain injury and compact technology in the operating suite, scientific paper presentations, refresher courses, and education exhibits will show how the modality continues to expand its utility.

November 14, 2011 -- With all of the attention being paid to reducing radiation dose to patients, ultrasound is getting a renewed look in many clinical indications. That new emphasis will be evident at the RSNA 2011 meeting, where a number of presentations will evaluate the utility of ultrasound versus CT, particularly in the bowel.

November 11, 2011 -- There will be much to learn in imaging informatics at RSNA 2011 as radiologists and IT professionals delve into the ways that informatics can improve the performance of a radiology department, assist daily work life, and look after patients' clinical management in ways that were unheard of before electronic healthcare records.

November 10, 2011 -- Wide-area detectors, dual-source scanners, fast kV switching, and new contrast protocols that leverage CT's growing spatial and temporal resolution are important sides of the CT picture that will be showcased in presentations at the RSNA 2011 meeting in Chicago.

November 09, 2011 -- For the RSNA 2011 conference, attendees will encounter sessions and posters that examine current issues in breast imaging, such as imaging of reconstructed breasts and management of high-risk lesions. Breast ultrasound also will be a highlight this year.

November 08, 2011 -- At this year's annual RSNA meeting, the advance of hybrid imaging and the development of new imaging agents are expected to be among the most intriguing developments in molecular imaging and nuclear medicine in Chicago.

November 07, 2011 -- PACS technology is always a hot topic at the RSNA meeting, and this year will be no different. Interest in mobile devices continues to explode, no doubt aided by the U.S. Food and Drug Administration's decision in early 2011 to clear an application for diagnostic use on Apple's iPad and iPhone.